Anavex Life Sciences
AVXL
#7563
Rank
S$0.50 B
Marketcap
S$5.70
Share price
-1.12%
Change (1 day)
-43.95%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): S-$0.76

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is S-$0.74. In 2024 the company made an earnings per share (EPS) of S-$0.67 an increase over its 2023 EPS that were of S-$0.78.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.7612.47%
2024S-$0.67-13.33%
2023S-$0.78-3.23%
2022S-$0.8014.81%
2021S-$0.7020%
2020S-$0.58-16.67%
2019S-$0.7038.46%
2018S-$0.5118.18%
2017S-$0.43-21.43%
2016S-$0.54-35.38%
2015S-$0.84-36.27%
2014S-$1.32112.5%
2013S-$0.62-58.62%
2012S-$1.50-0%
2011S-$1.50-29.27%
2010S-$2.1351.85%
2009S-$1.40-0%
2008S-$1.40237.5%
2007S-$0.41
2006N/A-100%
2005S-$0.05184499.97%
2004S-$0.008640

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
S$3.10-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S-$0.06479-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$1.30-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S-$79.05 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA